Cloud Pharmceuticals


cloud pharma logo
Launched:

2009

Duke Inventor(s):

Ed Addison

Cloud-based Drug Design and Development

Cloud Pharmaceuticals is committed to improving health and well-being through the computational design and rapid development of new therapies. Our proprietary design process combines artificial intelligence (AI) and cloud computing to search virtual molecular space and design novel drugs. These drugs are excellent candidates for further development and have a novel composition of matter IP. The process enables faster drug development progress at lower cost and a higher success rate and better targeting of hard-to-drug indications.
Our approach amplifies the power of cloud computing and AI to radically improve drug discovery and design. We partner at all stages of drug development – from discovery through the clinic – and are building an extensive product pipeline that spans a wide range of indications.

Technology

Cloud Pharmaceuticals delivers novel molecular designs of ligands to your druggable targets using our Quantum Molecular Design process deployed on cloud-based high performance computing platforms. The process is run by Cloud Pharmaceuticals’ experts in a high-throughput production environment and has three components:

  • An artificial Intelligence search of virtual chemical space
  • Highly accurate binding affinity prediction
  • Chemical property filters for drug-like properties, safety, and synthesizability